MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research (Q39625971)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 30, 2010

Language	Label	Description	Also known as
English	MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research	scientific article published on November 30, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Weifeng Ke

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Pei Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jianfeng Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ruitao Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Chongyong Guo

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ling Zhou

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Changchun Li

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ke Li

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s12032-010-9747-1.pdf

Portable Document Format

1 reference

10.1007/S12032-010-9747-1

https://api.crossref.org/works/10.1007/S12032-010-9747-1

4 September 2024

http://link.springer.com/article/10.1007/s12032-010-9747-1/fulltext.html

1 reference

10.1007/S12032-010-9747-1

https://api.crossref.org/works/10.1007/S12032-010-9747-1

4 September 2024

http://link.springer.com/content/pdf/10.1007/s12032-010-9747-1

1 reference

10.1007/S12032-010-9747-1

https://api.crossref.org/works/10.1007/S12032-010-9747-1

4 September 2024

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

28 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

S135-41

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

describes a project that uses

0 references

A gene expression database for the molecular pharmacology of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Multidrug-resistant MCF-7 cells: an identity crisis?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Proteomic phenotyping: metastatic and invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

DNA fingerprinting of the NCI-60 cell line panel

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Short tandem repeat profiling provides an international reference standard for human cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Proteomics reveals protein profile changes in doxorubicin--treated MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Topoisomerase II inhibition involves characteristic chromosomal expression patterns

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Persistent use of "false" cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Eradication of cross-contaminated cell lines: a call for action

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

UKCCCR guidelines for the use of cell lines in cancer research

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic complexity of the NCI-60 drug-screening panel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-010-9747-1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39625971&oldid=2243484534"